The story so far: On February 27, the Supreme Court restrained Patanjali Ayurved from discrediting allopathy in its campaigns, and from advertising products that claim to cure chronic conditions. Patanjali’s ads present its products to people as a ‘permanent relief’, which is “misleading” and “a violation of the law”, the Bench remarked, citing provisions of the Drugs and Magic Remedies (Objectionable Advertisements) Act, 1954 (DMR&OA) and its Rules.
Editorial | Science vs nonsense: On Patanjali’s COVID-19 claim
The Bench also issued a contempt notice against the company and its Managing Director Acharya Balkrishna for failing to adhere to directions passed in November last year. The “entire country has been taken for a ride”, the Bench said, while reprimanding the Union Government for its failure to take “urgent action”.
